Clinical Trial – Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer – Lung Cancer

This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer. Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

Study Type  : Observational
Estimated Enrollment  : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Predictors of Lung Cancer Behavior
Study Start Date  : December 2003
Estimated Primary Completion Date  : January 31, 2025
Estimated Study Completion Date  : January 31, 2025
Contacts
Contact: Vanderbilt Ingram Clinical Trials Information Program 1-800-811-8480

 

Locations
United States, Tennessee
Vanderbilt-Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37212
Contact: VICC Clinical Trials Information Program    800-811-8480    cip@vanderbilt.edu
Principal Investigator: Pierre Massion, MD
Veterans Affairs Medical Center – Nashville Recruiting
Nashville, Tennessee, United States, 37212
Contact: Research Office    615-873-8066
Contact: Rena Burns, RN    (615) 873-7658    Rena.Burns@va.gov
Principal Investigator: Pierre Massion, MD

 

ClinicalTrials.gov Identifier: NCT00898313

Leave a Reply